Drug information for AVINZA

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL 120MG Prescription  (Reference Drug) MORPHINE SULFATE Morphine KING PHARMS 21260
2008-12-23 Letter
2005-10-25 Letter
2005-10-24 Label
2004-01-15 Review
2002-03-20 Letter
2002-03-20 Label
CAPSULE, EXTENDED RELEASE; ORAL 30MG Prescription BX  MORPHINE SULFATE Morphine KING PHARMS   "
CAPSULE, EXTENDED RELEASE; ORAL 45MG Prescription   MORPHINE SULFATE Morphine KING PHARMS   "
CAPSULE, EXTENDED RELEASE; ORAL 60MG Prescription BX  MORPHINE SULFATE Morphine KING PHARMS   "
CAPSULE, EXTENDED RELEASE; ORAL 75MG Prescription   MORPHINE SULFATE Morphine KING PHARMS   "
CAPSULE, EXTENDED RELEASE; ORAL 90MG Prescription   MORPHINE SULFATE Morphine KING PHARMS   "

Drug Adverse Effects information for AVINZA

Role code Indications Reaction # Reports
PS CONNECTIVE TISSUE DISORDER EYELID OEDEMA 1
PS CONNECTIVE TISSUE DISORDER PIGMENTATION DISORDER 1
PS CONNECTIVE TISSUE DISORDER PRURITUS GENERALISED 1
PS CONNECTIVE TISSUE DISORDER RASH 1
PS CONNECTIVE TISSUE DISORDER WITHDRAWAL SYNDROME 1
PS PAIN DRUG INEFFECTIVE 1
PS PAIN PAIN 1
PS SPINAL FRACTURE ANXIETY 1
PS SPINAL FRACTURE DIARRHOEA 1
PS SPINAL FRACTURE DRUG DOSE OMISSION 1
PS SPINAL FRACTURE HYPERTENSION 1
PS SPINAL FRACTURE NAUSEA 1
SS SPINAL FRACTURE ANXIETY 1
SS SPINAL FRACTURE DIARRHOEA 1
SS SPINAL FRACTURE DRUG DOSE OMISSION 1
SS SPINAL FRACTURE HYPERTENSION 1
SS SPINAL FRACTURE NAUSEA 1
C BLOOD CHOLESTEROL ABNORMAL ADVERSE EVENT 1
C BLOOD CHOLESTEROL ABNORMAL AMNESIA 1
C BLOOD CHOLESTEROL ABNORMAL BARRETT'S OESOPHAGUS 1
C BLOOD CHOLESTEROL ABNORMAL CARDIAC ASSISTANCE DEVICE USER 1
C BLOOD CHOLESTEROL ABNORMAL DISABILITY 1
C BLOOD CHOLESTEROL ABNORMAL DRUG DOSE OMISSION 1
C BLOOD CHOLESTEROL ABNORMAL DRUG EFFECT DECREASED 1
C BLOOD CHOLESTEROL ABNORMAL DYSPEPSIA 1
C BLOOD CHOLESTEROL ABNORMAL DYSPHONIA 1
C BLOOD CHOLESTEROL ABNORMAL DYSPNOEA 1
C BLOOD CHOLESTEROL ABNORMAL INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C BLOOD CHOLESTEROL ABNORMAL INSOMNIA 1
C BLOOD CHOLESTEROL ABNORMAL NECK PAIN 1
C BLOOD CHOLESTEROL ABNORMAL ROAD TRAFFIC ACCIDENT 1
C BLOOD CHOLESTEROL ABNORMAL SPINAL FRACTURE 1
C BLOOD CHOLESTEROL ABNORMAL UPPER LIMB FRACTURE 1
C BLOOD TRIGLYCERIDES ABNORMAL ADVERSE EVENT 1
C BLOOD TRIGLYCERIDES ABNORMAL AMNESIA 1
C BLOOD TRIGLYCERIDES ABNORMAL BARRETT'S OESOPHAGUS 1
C BLOOD TRIGLYCERIDES ABNORMAL CARDIAC ASSISTANCE DEVICE USER 1
C BLOOD TRIGLYCERIDES ABNORMAL DISABILITY 1
C BLOOD TRIGLYCERIDES ABNORMAL DRUG DOSE OMISSION 1
C BLOOD TRIGLYCERIDES ABNORMAL DRUG EFFECT DECREASED 1
C BLOOD TRIGLYCERIDES ABNORMAL DYSPEPSIA 1
C BLOOD TRIGLYCERIDES ABNORMAL DYSPHONIA 1
C BLOOD TRIGLYCERIDES ABNORMAL DYSPNOEA 1
C BLOOD TRIGLYCERIDES ABNORMAL INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C BLOOD TRIGLYCERIDES ABNORMAL INSOMNIA 1
C BLOOD TRIGLYCERIDES ABNORMAL NECK PAIN 1
C BLOOD TRIGLYCERIDES ABNORMAL ROAD TRAFFIC ACCIDENT 1
C BLOOD TRIGLYCERIDES ABNORMAL SPINAL FRACTURE 1
C BLOOD TRIGLYCERIDES ABNORMAL UPPER LIMB FRACTURE 1
C DIABETES MELLITUS ADVERSE EVENT 1
C DIABETES MELLITUS AMNESIA 1
C DIABETES MELLITUS BARRETT'S OESOPHAGUS 1
C DIABETES MELLITUS CARDIAC ASSISTANCE DEVICE USER 1
C DIABETES MELLITUS DISABILITY 1
C DIABETES MELLITUS DRUG DOSE OMISSION 1
C DIABETES MELLITUS DRUG EFFECT DECREASED 1
C DIABETES MELLITUS DYSPEPSIA 1
C DIABETES MELLITUS DYSPHONIA 1
C DIABETES MELLITUS DYSPNOEA 1
C DIABETES MELLITUS INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C DIABETES MELLITUS INSOMNIA 1
C DIABETES MELLITUS NECK PAIN 1
C DIABETES MELLITUS ROAD TRAFFIC ACCIDENT 1
C DIABETES MELLITUS SPINAL FRACTURE 1
C DIABETES MELLITUS UPPER LIMB FRACTURE 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ANHEDONIA 5
C NUCLEAR MAGNETIC RESONANCE IMAGING ANXIETY 5
C NUCLEAR MAGNETIC RESONANCE IMAGING DRY SKIN 5
C NUCLEAR MAGNETIC RESONANCE IMAGING EMOTIONAL DISTRESS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING GENERAL PHYSICAL HEALTH DETERIORATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING JOINT CONTRACTURE 5
C NUCLEAR MAGNETIC RESONANCE IMAGING JOINT RANGE OF MOTION DECREASED 5
C NUCLEAR MAGNETIC RESONANCE IMAGING NEPHROGENIC SYSTEMIC FIBROSIS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING NEUROPATHIC ARTHROPATHY 5
C NUCLEAR MAGNETIC RESONANCE IMAGING OEDEMA 5
C NUCLEAR MAGNETIC RESONANCE IMAGING PAIN 5
C NUCLEAR MAGNETIC RESONANCE IMAGING POST INFLAMMATORY PIGMENTATION CHANGE 5
C NUCLEAR MAGNETIC RESONANCE IMAGING RASH GENERALISED 5
C NUCLEAR MAGNETIC RESONANCE IMAGING RASH MACULAR 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN EXFOLIATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN HYPERTROPHY 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN INDURATION 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN TIGHTNESS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING SKIN ULCER 5
C NUCLEAR MAGNETIC RESONANCE IMAGING STASIS DERMATITIS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING XEROSIS 5
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL ANHEDONIA 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL ANXIETY 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL DRY SKIN 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL EMOTIONAL DISTRESS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL GENERAL PHYSICAL HEALTH DETERIORATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL JOINT CONTRACTURE 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL JOINT RANGE OF MOTION DECREASED 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL NEPHROGENIC SYSTEMIC FIBROSIS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL NEUROPATHIC ARTHROPATHY 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL OEDEMA 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL PAIN 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL POST INFLAMMATORY PIGMENTATION CHANGE 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL RASH GENERALISED 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL RASH MACULAR 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL SKIN EXFOLIATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL SKIN HYPERTROPHY 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL SKIN INDURATION 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL SKIN TIGHTNESS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL SKIN ULCER 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL STASIS DERMATITIS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING ABDOMINAL XEROSIS 1
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ANHEDONIA 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ANXIETY 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN DRY SKIN 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN EMOTIONAL DISTRESS 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN GENERAL PHYSICAL HEALTH DETERIORATION 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN JOINT CONTRACTURE 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN JOINT RANGE OF MOTION DECREASED 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN NEPHROGENIC SYSTEMIC FIBROSIS 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN NEUROPATHIC ARTHROPATHY 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN OEDEMA 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN PAIN 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN POST INFLAMMATORY PIGMENTATION CHANGE 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN RASH GENERALISED 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN RASH MACULAR 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN EXFOLIATION 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN HYPERTROPHY 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN INDURATION 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN TIGHTNESS 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN SKIN ULCER 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN STASIS DERMATITIS 2
C NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN XEROSIS 2
C OEDEMA ADVERSE EVENT 1
C OEDEMA AMNESIA 1
C OEDEMA BARRETT'S OESOPHAGUS 1
C OEDEMA CARDIAC ASSISTANCE DEVICE USER 1
C OEDEMA DISABILITY 1
C OEDEMA DRUG DOSE OMISSION 1
C OEDEMA DRUG EFFECT DECREASED 1
C OEDEMA DYSPEPSIA 1
C OEDEMA DYSPHONIA 1
C OEDEMA DYSPNOEA 1
C OEDEMA INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C OEDEMA INSOMNIA 1
C OEDEMA NECK PAIN 1
C OEDEMA ROAD TRAFFIC ACCIDENT 1
C OEDEMA SPINAL FRACTURE 1
C OEDEMA UPPER LIMB FRACTURE 1
C OSTEOPOROSIS NASOPHARYNGITIS 1
C OSTEOPOROSIS PANCREATIC CARCINOMA METASTATIC 1
C OSTEOPOROSIS VIRAL INFECTION 1
C PAIN ADVERSE EVENT 2
C PAIN AMNESIA 2
C PAIN BARRETT'S OESOPHAGUS 2
C PAIN CARDIAC ASSISTANCE DEVICE USER 2
C PAIN DISABILITY 2
C PAIN DRUG DOSE OMISSION 2
C PAIN DRUG EFFECT DECREASED 2
C PAIN DYSPEPSIA 2
C PAIN DYSPHONIA 2
C PAIN DYSPNOEA 2
C PAIN INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
C PAIN INSOMNIA 2
C PAIN NECK PAIN 2
C PAIN ROAD TRAFFIC ACCIDENT 2
C PAIN SPINAL FRACTURE 2
C PAIN UPPER LIMB FRACTURE 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS ASTHENIA 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS BALANCE DISORDER 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS CONFUSIONAL STATE 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS INCORRECT DOSE ADMINISTERED 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS SINUSITIS 2
C RELAPSING-REMITTING MULTIPLE SCLEROSIS TREMOR 2
C THYROID DISORDER ADVERSE EVENT 1
C THYROID DISORDER AMNESIA 1
C THYROID DISORDER BARRETT'S OESOPHAGUS 1
C THYROID DISORDER CARDIAC ASSISTANCE DEVICE USER 1
C THYROID DISORDER DISABILITY 1
C THYROID DISORDER DRUG DOSE OMISSION 1
C THYROID DISORDER DRUG EFFECT DECREASED 1
C THYROID DISORDER DYSPEPSIA 1
C THYROID DISORDER DYSPHONIA 1
C THYROID DISORDER DYSPNOEA 1
C THYROID DISORDER INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C THYROID DISORDER INSOMNIA 1
C THYROID DISORDER NECK PAIN 1
C THYROID DISORDER ROAD TRAFFIC ACCIDENT 1
C THYROID DISORDER SPINAL FRACTURE 1
C THYROID DISORDER UPPER LIMB FRACTURE 1
C VITAMIN D DECREASED NASOPHARYNGITIS 1
C VITAMIN D DECREASED PANCREATIC CARCINOMA METASTATIC 1
C VITAMIN D DECREASED VIRAL INFECTION 1
Ads by Google